title: Epithelial cell apoptosis facilitates Entamoeba histolytica infection in the gut.
abstract: Entamoeba histolytica is the protozoan parasite that causes amebic colitis. The parasite triggers apoptosis on contact with host cells; however, the biological significance of this event during intestinal infection is unclear. We examined the role of apoptosis in a mouse model of intestinal amebiasis. Histopathology revealed that abundant epithelial cell apoptosis occurred in the vicinity of amoeba in histological specimens. Epithelial cell apoptosis occurred rapidly on co-culture with amoeba in vitro as measured by annexin positivity, DNA degradation, and mitochondrial dysfunction. Administration of the pan caspase inhibitor ZVAD decreased the rate and severity of amebic infection in CBA mice by all measures (cecal culture positivity, parasite enzyme-linked immunosorbent assay, and histological scores). Similarly, caspase 3 knockout mice on the resistant C57BL/6 background exhibited even lower cecal parasite antigen burden and culture positive rates than wild type mice. The permissive effect of apoptosis on infection could be tracked to the epithelium, in that transgenic mice that overexpressed Bcl-2 in epithelial cells were more resistant to infection as measured by cecal parasite enzyme-linked immunosorbent assay and histological scores. We concluded that epithelial cell apoptosis in the intestine facilitates amebic infection in this mouse model. The parasite's strategy for inducing apoptosis may point to key virulence factors, and therapeutic maneuvers to diminish epithelial apoptosis may be useful in amebic colitis.
authors.affiliation: Division of Infectious Diseases and International Health, Department of Medicine, University of Virginia, Charlottesville, VA 22908, USA.
authors.forename: Stephen M
authors.initials: SM
authors.lastname: Becker
authors.forename: Kyou-Nam
authors.initials: KN
authors.lastname: Cho
authors.forename: Xiaoti
authors.initials: X
authors.lastname: Guo
authors.forename: Kirsten
authors.initials: K
authors.lastname: Fendig
authors.forename: Mohammed N
authors.initials: MN
authors.lastname: Oosman
authors.forename: Robert
authors.initials: R
authors.lastname: Whitehead
authors.forename: Steven M
authors.initials: SM
authors.lastname: Cohn
authors.forename: Eric R
authors.initials: ER
authors.lastname: Houpt
mesh_terms: D000818:Animals; D017209:Apoptosis; D053148:Caspase 3 / Q000172:deficiency; D061945:Caspase Inhibitors; D002432:Cecum / Q000201:enzymology / Q000469:parasitology / Q000473:pathology; D004195:Disease Models, Animal; D004404:Dysentery, Amebic / Q000201:enzymology / Q000469:parasitology* / Q000473:pathology*; D004748:Entamoeba histolytica / Q000502:physiology*; D004847:Epithelial Cells / Q000469:parasitology / Q000473:pathology*; D041981:Gastrointestinal Tract / Q000469:parasitology* / Q000473:pathology*; D008297:Male; D051379:Mice; D008822:Mice, Transgenic; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism
chemical_list: D061945:Caspase Inhibitors; D019253:Proto-Oncogene Proteins c-bcl-2; D053148:Caspase 3